Total Payments
$513.87
2024 Payments
$23.27
Companies
11
Transactions
27
Medicare Patients
4,443
Medicare Billing
$584,787
Payment Breakdown by Category
Food & Beverage$513.87 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $513.87 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SI-BONE, Inc. | $145.34 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $76.72 | 6 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58.38 | 4 | $0 (2019) |
| PFIZER INC. | $47.81 | 4 | $0 (2018) |
| Novo Nordisk Inc | $41.90 | 2 | $0 (2024) |
| Lilly USA, LLC | $40.36 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $37.46 | 2 | $0 (2018) |
| Medtronic MiniMed, Inc. | $26.02 | 2 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $16.79 | 1 | $0 (2019) |
| Amgen Inc. | $12.03 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.27 | 1 | Novo Nordisk Inc ($23.27) |
| 2023 | $17.82 | 1 | Lilly USA, LLC ($17.82) |
| 2022 | $145.34 | 1 | SI-BONE, Inc. ($145.34) |
| 2019 | $65.21 | 4 | Novartis Pharmaceuticals Corporation ($28.69) |
| 2018 | $146.78 | 11 | Novartis Pharmaceuticals Corporation ($48.03) |
| 2017 | $115.45 | 9 | PFIZER INC. ($35.78) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Diabetes | ||||||
| 06/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | SI-BONE, Inc. | — | Food and Beverage | Cash or cash equivalent | $145.34 | General |
| 06/19/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: DIABETES | ||||||
| 03/27/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2018 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Neuroscience | ||||||
| 10/29/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/26/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $10.83 | General |
| 05/16/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: DIABETES | ||||||
| 04/24/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/15/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: DIABETES | ||||||
| 02/27/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: RESPIRATORY | ||||||
| 02/14/2018 | Medtronic MiniMed, Inc. | iPro2 (Device) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 02/07/2018 | Medtronic MiniMed, Inc. | iPro2 (Device) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 12/19/2017 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/12/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: DERMATOLOGY | ||||||
| 09/11/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Diabetes | ||||||
| 08/31/2017 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/30/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 08/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,017 | 2,177 | $322,448 | $135,309 |
| 2022 | 22 | 1,240 | 2,835 | $384,879 | $169,396 |
| 2021 | 18 | 1,215 | 2,739 | $355,163 | $161,738 |
| 2020 | 17 | 971 | 2,152 | $314,410 | $118,344 |
Total Patients
4,443
Total Services
9,903
Medicare Billing
$584,787
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 311 | 1,249 | $237,310 | $97,517 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 143 | 143 | $31,889 | $17,146 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 119 | $15,351 | $6,891 | 44.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 41 | 41 | $4,715 | $3,032 | 64.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 83 | 85 | $3,230 | $2,438 | 75.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 123 | 123 | $9,225 | $2,071 | 22.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 14 | 37 | $2,627 | $1,058 | 40.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 46 | 48 | $4,080 | $1,051 | 25.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 25 | 25 | $1,875 | $973.20 | 51.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 34 | 99 | $4,257 | $864.70 | 20.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 21 | $798.00 | $602.28 | 75.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 12 | $1,392 | $588.24 | 42.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 12 | $1,128 | $461.16 | 40.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 28 | $1,204 | $454.16 | 37.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 43 | $1,075 | $94.60 | 8.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 36 | $1,620 | $41.68 | 2.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 11 | 56 | $672.00 | $24.05 | 3.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 357 | 1,355 | $257,450 | $111,116 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 124 | 124 | $27,674 | $15,330 | 55.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 195 | $25,155 | $11,158 | 44.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 68 | 293 | $19,924 | $8,216 | 41.2% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 16 | 16 | $5,600 | $4,042 | 72.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 43 | 43 | $4,915 | $3,017 | 61.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 96 | 97 | $3,686 | $2,633 | 71.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $4,104 | $2,242 | 54.6% |
About Dr. Jonathon Long, MD
Dr. Jonathon Long, MD is a Family Medicine healthcare provider based in Weatherford, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477758423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathon Long, MD has received a total of $513.87 in payments from pharmaceutical and medical device companies, with $23.27 received in 2024. These payments were reported across 27 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($513.87).
As a Medicare-enrolled provider, Long has provided services to 4,443 Medicare beneficiaries, totaling 9,903 services with total Medicare billing of $584,787. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Weatherford, OK
- Active Since 06/19/2007
- Last Updated 08/29/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1477758423
Products in Payments
- ENTRESTO (Drug) $52.22
- JARDIANCE (Drug) $43.67
- ANORO (Drug) $37.46
- CHANTIX (Drug) $33.93
- iPro2 (Device) $26.02
- Rybelsus (Drug) $23.27
- TRULICITY (Drug) $22.54
- Victoza (Drug) $18.63
- MOUNJARO (Drug) $17.82
- LONHALA MAGNAIR (Drug) $16.79
- STIOLTO (Drug) $14.71
- EUCRISA (Drug) $13.88
- AIMOVIG (Biological) $13.67
- Aimovig (Biological) $12.03
- JANUVIA (Drug) $11.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weatherford
Adam Khadbai, M.d, M.D
Family Medicine — Payments: $18,816
Family Medicine $18,816
Rupa Pachigolla, M.d, M.D
Family Medicine — Payments: $9,183
Family Medicine $9,183
Steven Melcher, M.d, M.D
Family Medicine — Payments: $5,814
Family Medicine $5,814
Robert Miller, Md, MD
Family Medicine — Payments: $5,529
Family Medicine $5,529
Dr. Blake Badgett, M.d, M.D
Family Medicine — Payments: $4,884
Family Medicine $4,884
Miguel Gutierrez, Md, MD
Family Medicine — Payments: $4,767
Family Medicine $4,767